Nate Pennell

Dr. Nate Pennell, co-director of the Cleveland Clinic Lung Cancer Program, shares insights on revolutionary lung cancer treatments. They discuss groundbreaking findings on the timing of immunotherapy, revealing that administering treatment in the morning may boost survival rates. The conversation transitions to innovative use of ctDNA for personalized immunotherapy, and they delve into promising results from neoadjuvant treatments, emphasizing advancements in overall survival. Additionally, they touch on the challenges faced in gaining FDA approvals for new therapies.